Literature DB >> 11789334

An experimental study on drugs for improving blood circulation and removing blood stasis in treating mild chronic hepatic damage.

F Xie1, X Li, K Sun, Y Chu, H Cao, N Chen, W Wang, M Liu, W Liu, D Mao.   

Abstract

Large and small doses of drugs for improving blood circulation and removing blood stasis were used in model rats to treat mild chronic hepatic damage induced by carbon tetrachloride (CCl4). The results show that large dose of Dang Gui ([symbol: see text] Radix Angelicae Sinensis) and Dan Shen ([symbol: see text] Radix Salviae Miltiorrhizae) (drugs for regulating blood flow) and small dose of Yu Jin ([symbol: see text] Radix Curcumae) and Niu Xi ([symbol: see text] Radix Achyranthis Bidentatae) (drugs for activating blood flow) can significantly elevate the activity of SOD (P < 0.05) and/or lower the T/K ratio, markedly reduce the MDA content (P < 0.05 or P < 0.01) and significantly decrease the activities of ALT and AST (P < 0.05 or P < 0.01), demonstrating that these drugs are effective in combating oxygen free radicals (OFR) in chronic liver damage. On the contrary, large dose of Tu Bie Chong ([symbol: see text] Eupolyphaga seu Steleophaga) and E Zhu ([symbol: see text] Rhizoma Curcumae) (drugs for removing blood stasis) tend to increase the ALT and AST (P < 0.05) activities. The results suggest that the synergism of elevation of the SOD activity and reduction of T/K ratio contributes to the action of drugs for improving blood circulation and removing blood stasis in combating the liver damage induced by CCl4.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11789334

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  8 in total

1.  Herbal cardiotonic pills prevent gut ischemia/reperfusion-induced hepatic microvascular dysfunction in rats fed ethanol chronically.

Authors:  Yoshinori Horie; Jing-Yan Han; Shuka Mori; Masahiro Konishi; Mikio Kajihara; Takehiko Kaneko; Yoshiyuki Yamagishi; Shinzo Kato; Hiromasa Ishii; Toshifumi Hibi
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

2.  Angelica Sinensis attenuates inflammatory reaction in experimental rat models having spinal cord injury.

Authors:  Jun Xu; Xiao-Qiang E; Hui-Yong Liu; Jun Tian; Jing-Long Yan
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 3.  Traditional Chinese Medications for Knee Osteoarthritis Pain: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Bo Chen; Hongsheng Zhan; Jolanta Marszalek; Mei Chung; Xun Lin; Min Zhang; Jian Pang; Chenchen Wang
Journal:  Am J Chin Med       Date:  2016-05-24       Impact factor: 4.667

4.  An Experimental Novel Study: Angelica sinensis Prevents Epidural Fibrosis in Laminectomy Rats via Downregulation of Hydroxyproline, IL-6, and TGF- β 1.

Authors:  Chao Zhang; Xiaohong Kong; Hengxing Zhou; Chang Liu; Xuechao Zhao; Xianhu Zhou; Yanhua Su; Hari S Sharma; Shiqing Feng
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-29       Impact factor: 2.629

5.  Effects of goshajinkigan, hachimijiogan, and rokumigan on mechanical allodynia induced by Paclitaxel in mice.

Authors:  Tsugunobu Andoh; Ryo Kitamura; Hirotoshi Fushimi; Katsuko Komatsu; Naotoshi Shibahara; Yasushi Kuraishi
Journal:  J Tradit Complement Med       Date:  2014-10

6.  Ethyl acetate fraction from Angelica sinensis inhibits IL-1β-induced rheumatoid synovial fibroblast proliferation and COX-2, PGE2, and MMPs production.

Authors:  Won-Seok Lee; Jin-Han Lim; Myung-Soon Sung; Eun-Gyeong Lee; Yoo-Jeong Oh; Wan-Hee Yoo
Journal:  Biol Res       Date:  2014-09-05       Impact factor: 5.612

Review 7.  A periodic review of chemical and pharmacological profiles of Tubiechong as insect Chinese medicine.

Authors:  Jiayu Xie; Dapeng Zhang; Cheng Liu; Lingchong Wang
Journal:  RSC Adv       Date:  2021-10-19       Impact factor: 4.036

8.  Evaluation on the combined effect of Sesamin and Schisandra extract on blood fluidity.

Authors:  Daniel Tsi; Amabel Tan
Journal:  Bioinformation       Date:  2008-01-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.